Two new subtypes of HPV+ head and neck cancers identified

Cases of human papillomavirus (HPV)-associated cancers of the head and neck, known as head and neck squamous cell carcinoma (HNSCC), are rapidly increasing throughout the United States.

GSK defiant against vaccine challenges, will prioritize other growth areas

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

February 6, 2025

Sonio Launches AI-Powered Voice for Ultrasound Reporting

What You Should Know: – Sonio, a global provider of AI-driven medical technology innovation announced the launch of Sonio Voice, a cutting-edge voice recognition solution

January 27, 2025

Selective Role for Single-Agent Ipilimumab After Anti-PD-1 Failure in Melanoma

Patients with wild-type metastatic melanoma that progressed on frontline PD-1 inhibition had almost a 2-year median overall survival (OS) when treated with single-agent ipilimumab (Yervoy),

October 9, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.